DAVID EMERSON JORDEN Insider Trading
Get free email notifications about insider trading for DAVID EMERSON JORDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID EMERSON JORDEN. DAVID EMERSON JORDEN is a Acting CFO in Nuo Therapeutics, Inc. ($NUOT) and a CEO and CFO in Nuo Therapeutics, Inc. ($NUOT) and a CEO, CFO in Nuo Therapeutics, Inc. ($NUOT) and a Director in Nuo Therapeutics, Inc. ($NUOT) and a Acting Chief Financial Officer in PLx Pharma Inc. ($DPRX).
Address: 416 HUNGERFORD DRIVE SUITE 330 ROCKVILLE 20850 MD
Companies in which DAVID EMERSON JORDEN is an Insider
Nuo Therapeutics, Inc.
Trading Symbol: AURXIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID EMERSON JORDEN: CEO, CFO, CEO and CFO, Acting CFO, Director
Holdings: 557,146 shares
Current Value: $5,571
Latest Transaction: Jan 03 2019
$AURX Market Capitalization: $1.82M
$AURX Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PLx Pharma Inc.
Trading Symbol: PLXPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID EMERSON JORDEN: Acting Chief Financial Officer
Holdings: 151,913 shares
Current Value: $205,083
Latest Transaction: Jun 16 2017
$PLXP Market Capitalization: $15.01M
$PLXP Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID EMERSON JORDEN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2019 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 125,000 | 50,000 | 125,000 | |
Aug 13 2018 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 192,710 | 77,084 | 192,710 | |
Aug 14 2017 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Buy | P | 0.22 | 247,500 | 54,995 | 557,146 | 309.6 K to 557.1 K (+79.93 %) |
Jun 16 2017 | DPRX | PLx Pharma Inc. | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | P | 7.50 | 32,727 | 245,453 | 32,727 | |
Jun 16 2017 | DPRX | PLx Pharma Inc. | JORDEN DAVID EMERSON | Acting Chief Financ ... | Buy | P | 6.88 | 32,727 | 224,998 | 151,913 | 119.2 K to 151.9 K (+27.46 %) |
Apr 20 2017 | DPRX | PLx Pharma Inc. | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 12.44 | 33,753 | 419,887 | 33,753 | |
Apr 20 2017 | DPRX | PLx Pharma Inc. | JORDEN DAVID EMERSON | Acting Chief Financ ... | Grant | A | 0.00 | 119,186 | 0 | 119,186 | 0 to 119.2 K |